Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$27.7 - $31.39 $37.4 Million - $42.4 Million
-1,349,308 Reduced 12.93%
9,088,319 $263 Million
Q2 2024

Jul 29, 2024

SELL
$25.26 - $29.6 $16.6 Million - $19.5 Million
-657,172 Reduced 5.92%
10,437,627 $292 Million
Q1 2024

Apr 29, 2024

SELL
$25.89 - $29.73 $1.23 Million - $1.41 Million
-47,467 Reduced 0.43%
11,094,799 $308 Million
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $18.1 Million - $23.5 Million
-693,695 Reduced 5.86%
11,142,266 $321 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $2.34 Million - $2.73 Million
-72,872 Reduced 0.61%
11,835,961 $393 Million
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $7.88 Million - $9.11 Million
218,037 Added 1.87%
11,908,833 $437 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $3.85 Million - $5.01 Million
97,672 Added 0.84%
11,690,796 $477 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $7.74 Million - $10.1 Million
-185,484 Reduced 1.57%
11,593,124 $594 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $164,143 - $200,378
3,751 Added 0.03%
11,778,608 $515 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $26.4 Million - $31.3 Million
566,590 Added 5.06%
11,774,857 $617 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $8.46 Million - $10.5 Million
185,005 Added 1.68%
11,208,267 $580 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $63.9 Million - $94.7 Million
-1,546,449 Reduced 12.3%
11,023,262 $650 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $31.5 Million - $40.4 Million
801,981 Added 6.82%
12,569,711 $541 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $15.3 Million - $17.3 Million
426,033 Added 3.76%
11,767,730 $461 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $18.4 Million - $20.8 Million
-549,449 Reduced 4.62%
11,341,697 $411 Million
Q4 2020

Feb 23, 2021

SELL
$33.47 - $42.56 $635 - $808
-19 Reduced -0.0%
11,891,146 $438 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $25.5 Million - $32.5 Million
-763,041 Reduced 6.03%
11,891,165 $438 Million
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $24.1 Million - $28.2 Million
-757,821 Reduced 5.65%
12,654,206 $441 Million
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $17.7 Million - $21.5 Million
587,393 Added 4.58%
13,412,027 $439 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $835,551 - $1.19 Million
-30,912 Reduced 0.24%
12,824,634 $419 Million
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $9.82 Million - $11.1 Million
-298,356 Reduced 2.27%
12,855,546 $504 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $9.77 Million - $12.7 Million
-300,603 Reduced 2.23%
13,153,902 $473 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $30 Million - $33.7 Million
-811,687 Reduced 5.69%
13,454,505 $583 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $18.2 Million - $20 Million
-486,491 Reduced 3.3%
14,266,192 $606 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $20.7 Million - $23.6 Million
-538,124 Reduced 3.52%
14,752,683 $644 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $18 Million - $21.8 Million
-521,205 Reduced 3.3%
15,290,807 $674 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $22.3 Million - $23.8 Million
676,998 Added 4.47%
15,812,012 $0
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $4.76 Million - $5.52 Million
149,146 Added 1.0%
15,135,014 $537 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $6.11 Million - $6.49 Million
183,810 Added 1.24%
14,985,868 $543 Million
Q3 2017

Nov 02, 2017

BUY
$31.0 - $34.15 $459 Million - $505 Million
14,802,058
14,802,058 $528 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.